You
← Back to results
EX
Exelixis, Inc.Company · Health · CA
RealCurrent
Mission statement · Company scope

“Our mission is to maximize the clinical and commercial potential of cabozantinib, and to position us for future growth through our discovery efforts and expansion of our development pipeline.”

MissionInnovationLeads with inventionClimate & health
✎ Write one like this
In use2019 – now1 sighting
First seenFeb 2019Added
Last seenFeb 2019Latest observation
Date created—Not published by the organization
Record
Kind
Mission
Scope
Company
Style
Innovation (primary)
Leads with
Invention
Best for
Climate & health
Formula
We’re building [new thing] so [result]
Tone
Aspirational
Length
29 words · reading grade 18.5
Review status
unreviewed · classifier rules-v0
Quality score
0.75
Record
st_77dfaca18baee151
Classification confidence
0.75
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2019-02-22 · sec_sentence · 10-K · accession 0000939767-19-000042
View filing ↗
Report an issueReports are reviewed within 3 working days.
0 to compareCompare